Provocation Tests Should Be Done to Unmask Brugada Syndrome

Description

This session will review risk stratification in pediatric patients with Brugada syndrome.

Learning Objectives

Review the evidence that provocation with sodium channel blockers can guide diagnosis, management and risk stratification in pediatric patients with Brugada syndrome
Discuss approach to the evaluation of patients at risk of Brugada syndrome in families without a genetic marker, including sodium channel blocking provocation and timing of investigations
Discuss counselling a patient and their family about sodium channel provocation in Brugada syndrome

Session Chair(s)

Martin LaPage, MD
Sami Viskin, MD

Presentation

PRO
Presenter(s): M. Cecilia Gonzalez Corcia, PhD

CON
Presenter(s): Georgia Sarquella-Brugada, MD, PhD

Rebuttal
Presenter(s): M. Cecilia Gonzalez Corcia, PhD

Rebuttal
Presenter(s): Georgia Sarquella-Brugada, MD, PhD

Disclosures

M. Cecilia Gonzalez Corcia:

Nothing Relevant to Disclose

Georgia Sarquella-Brugada:

Biotronik (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
CORDIS – Johnson & Johnson (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

M. Cecilia Gonzalez Corcia:

Nothing Relevant to Disclose

Georgia Sarquella-Brugada:

Biotronik (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
CORDIS – Johnson & Johnson (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Other Arrhythmia Syndromes
-- Inherited Arrhythmia Syndromes and Genetic Testing
-- 254. Know the most common ion channel mutations associated with Brugada Syndrome and the phenotype and arrhythmia risks.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE